SWKS
53
-3
A
62
2
KEY
57
-3
DE
40
4
PVH
42
3
BEN
30
-4
HP
48
-5
CVX
40
2
EA
52
-3
BMY
50
2
AEE
68
-3
YUM
65
2
AN
52
-2
ETN
57
-2
V
42
-2
CPB
37
2
FDX
64
10
LLY
62
3
MU
66
-2
PEG
46
-2
SWKS
53
-3
A
62
2
KEY
57
-3
DE
40
4
PVH
42
3
BEN
30
-4
HP
48
-5
CVX
40
2
EA
52
-3
BMY
50
2
AEE
68
-3
YUM
65
2
AN
52
-2
ETN
57
-2
V
42
-2
CPB
37
2
FDX
64
10
LLY
62
3
MU
66
-2
PEG
46
-2
Financhill
Back

Simmons First National Corp. - Ordinary Shares - Class A Vs. Cidara Therapeutics Industry Stock Comparison

Buy
66

SFNC
Simmons First National Corp. - Ordinary Shares - Class A

Last Price:
$19.83
Seasonality Move:
2.47%
Buy
80

CDTX
Cidara Therapeutics

Last Price:
$65.20
Seasonality Move:
2.23%
Buy
66
Simmons First National Corp. - Ordinary Shares - Class A (SFNC) is a Buy

Is Simmons First National Corp. - Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Simmons First National Corp. - Ordinary Shares - Class A [SFNC] share price is $19.83. The Score for SFNC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • SFNC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $65.22. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SFNC Stock Price Chart

What is Simmons First National Corp. - Ordinary Shares - Class A's stock price today?

  • The Simmons First National Corp. - Ordinary Shares - Class A share price today is $19.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFNC is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $65.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SFNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.83 Buy
Relative Strength Index (14 RSI): 55.94 Buy
Chaikin Money Flow: -714996 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.11 - 19.99) Buy
Bollinger Bands (100): (18.41 - 19.99) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.52 Buy
Relative Strength Index (14 RSI): 72.5 Buy
Chaikin Money Flow: 325218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.36 - 64.38) Buy
Bollinger Bands (100): (17.47 - 52.87) Buy

SFNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.41 Buy
20-day SMA: 19.5 Buy
50-day SMA: 19.34 Buy
200-day SMA: 20.98 Sell
8-day EMA: 19.03 Buy
20-day EMA: 14.65 Buy
50-day EMA: 8.31 Buy
200-day EMA: 2.53 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.72 Buy
20-day SMA: 62.33 Buy
50-day SMA: 49.33 Buy
200-day SMA: 27.87 Buy
8-day EMA: 61.33 Buy
20-day EMA: 47.32 Buy
50-day EMA: 26.86 Buy
200-day EMA: 8.18 Buy

Simmons First National Corp. - Ordinary Shares - Class A Earnings Growth & SFNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.03 per share, an increase this year of $0.31 per share, and an increase next year of $0.28 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.

Simmons First National Corp. - Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):